Parametric Portfolio Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $628M | Buy |
2,595,883
+172,109
| +7% | +$39.5M | 0.33% | 53 |
|
|
2021
Q4 | $545M | Buy |
2,423,774
+28,537
| +1% | +$6.02M | 0.28% | 60 |
|
|
2021
Q3 | $509M | Sell |
2,395,237
-753,985
| -24% | -$174M | 0.29% | 61 |
|
|
2021
Q2 | $768M | Buy |
3,149,222
+36,654
| +1% | +$9.02M | 0.43% | 34 |
|
|
2021
Q1 | $774M | Buy |
3,112,568
+36,603
| +1% | +$8.73M | 0.44% | 31 |
|
|
2020
Q4 | $707M | Buy |
3,075,965
+98,057
| +3% | +$22.6M | 0.44% | 35 |
|
|
2020
Q3 | $757M | Buy |
2,977,908
+202,017
| +7% | +$50M | 0.54% | 26 |
|
|
2020
Q2 | $655M | Buy |
2,775,891
+197,121
| +8% | +$45M | 0.5% | 28 |
|
|
2020
Q1 | $523M | Buy |
2,578,770
+182,537
| +8% | +$39.9M | 0.48% | 30 |
|
|
2019
Q4 | $578M | Buy |
2,396,233
+42,873
| +2% | +$9.45M | 0.42% | 35 |
|
|
2019
Q3 | $455M | Buy |
2,353,360
+154,094
| +7% | +$29.6M | 0.37% | 39 |
|
|
2019
Q2 | $405M | Sell |
2,199,266
-102,742
| -4% | -$18.4M | 0.33% | 44 |
|
|
2019
Q1 | $437M | Sell |
2,302,008
-31,312
| -1% | -$5.98M | 0.38% | 40 |
|
|
2018
Q4 | $454M | Buy |
2,333,320
+42,806
| +2% | +$8.35M | 0.45% | 36 |
|
|
2018
Q3 | $475M | Sell |
2,290,514
-45,694
| -2% | -$9.01M | 0.42% | 35 |
|
|
2018
Q2 | $431M | Sell |
2,336,208
-59,467
| -2% | -$10.5M | 0.41% | 36 |
|
|
2018
Q1 | $408M | Buy |
2,395,675
+47,832
| +2% | +$8.78M | 0.4% | 39 |
|
|
2017
Q4 | $408M | Buy |
2,347,843
+13,990
| +0.6% | +$2.48M | 0.41% | 40 |
|
|
2017
Q3 | $435M | Buy |
2,333,853
+85,238
| +4% | +$15.1M | 0.47% | 34 |
|
|
2017
Q2 | $387M | Buy |
2,248,615
+734,381
| +48% | +$119M | 0.46% | 35 |
|
|
2017
Q1 | $248M | Sell |
1,514,234
-346,642
| -19% | -$57.6M | 0.38% | 39 |
|
|
2016
Q4 | $272M | Sell |
1,860,876
-31,177
| -2% | -$4.69M | 0.38% | 43 |
|
|
2016
Q3 | $316M | Buy |
1,892,053
+100,698
| +6% | +$17M | 0.47% | 34 |
|
|
2016
Q2 | $273M | Buy |
1,791,355
+62,876
| +4% | +$9.78M | 0.43% | 36 |
|
|
2016
Q1 | $259M | Sell |
1,728,479
-40,275
| -2% | -$5.98M | 0.42% | 38 |
|
|
2015
Q4 | $287M | Buy |
1,768,754
+47,267
| +3% | +$7.43M | 0.49% | 34 |
|
|
2015
Q3 | $238M | Buy |
1,721,487
+244,274
| +17% | +$38.5M | 0.46% | 41 |
|
|
2015
Q2 | $227M | Buy |
1,477,213
+77,594
| +6% | +$12.4M | 0.44% | 36 |
|
|
2015
Q1 | $224M | Buy |
1,399,619
+50,271
| +4% | +$7.92M | 0.45% | 36 |
|
|
2014
Q4 | $215M | Buy |
1,349,348
+6,235
| +0.5% | +$972K | 0.45% | 35 |
|
|
2014
Q3 | $189M | Sell |
1,343,113
-54,828
| -4% | -$7.16M | 0.42% | 40 |
|
|
2014
Q2 | $165M | Sell |
1,397,941
-15,537
| -1% | -$1.8M | 0.37% | 39 |
|
|
2014
Q1 | $174M | Sell |
1,413,478
-21,107
| -1% | -$2.56M | 0.41% | 38 |
|
|
2013
Q4 | $164M | Sell |
1,434,585
-7,460
| -0.5% | -$849K | 0.4% | 38 |
|
|
2013
Q3 | $161M | Sell |
1,442,045
-24,229
| -2% | -$2.63M | 0.44% | 33 |
|
|
2013
Q2 | $145M | Buy |
+1,466,274
| New | +$152M | 0.42% | 35 |
|
Other funds holding AMGN
Parametric Portfolio Associates's AMGN Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Amgen (AMGN) stake by 7.1% in Q1 2022, buying an estimated $39.5M and bringing the position to 2,595,883 shares worth $628M. The position accounts for 0.33% of the portfolio, ranked #53.
Parametric Portfolio Associates first reported a position in AMGN in Q2 2013 and has held it in 36 quarters since. The position peaked at $774M in Q1 2021. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.
- Parametric Portfolio Associates held 2,595,883 shares of Amgen worth $628M as of Q1 2022.
- Parametric Portfolio Associates bought 172,109 Amgen shares in Q1 2022, an estimated $39.5M.
- Amgen made up 0.33% of Parametric Portfolio Associates's portfolio in Q1 2022, its #53 holding.
- Parametric Portfolio Associates first reported a position in Amgen in Q2 2013 and has held it in 36 quarters since.
- Parametric Portfolio Associates's Amgen position peaked at $774M in Q1 2021.
- 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.